Safety and tolerability during build-up phase of a rush venom immunotherapy

Safety and tolerability of venom immunotherapy (VIT) in patients with concomitant disease and comedications, especially β-blockers (BBs) and angiotensin-converting enzyme inhibitors (ACEIs), are under discussion.

from #ENT via xlomafota13 on Inoreader http://ift.tt/1pZd35G
via IFTTT